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Abstract  
IR multiple photon dissociation spectroscopy of cis-[Pt(NH3)2(G)Cl]
+
 and cis-
[Pt(NH3)2(A)Cl]
+
 ions (where A is adenine and G is guanine) has been performed in two 
spectral regions, namely 950-1900 cm
-1
 and 2900-3700 cm
-1
. Quantum chemical 
calculations at the B3LYP/LACV3P/6-311G** level, yield the optimized geometries and IR 
spectra for the conceivable isomers of cis-[Pt(NH3)2(G)Cl]
+
 and cis-[Pt(NH3)2(A)Cl]
+
, 
whereby the cisplatin residue is attached to either the N7, N3 or to the carbonyl oxygen 
atom (O6) of guanine, and either to the N7, N3 or N1 position of adenine, respectively. In 
addition to the conventional binding sites of native adenine, complexes with N7-H 
tautomers have also been considered. In agreement with computational results the IR 
characterization of cis-[Pt(NH3)2(G)Cl]
+
 points to a covalent structure where Pt is bound to 
the N7 atom of guanine. The characterized conformer has a hydrogen bonding interaction 
between a hydrogen atom of one NH3 ligand and the carbonyl group of guanine. The 
experimental C=O stretching feature of cis-[Pt(NH3)2(G)Cl]
+
 at 1718 cm
-1
, remarkably red-
shifted with respect to an unperturbed C=O stretching mode, is indicative of a lengthened 
CO bond in guanine, a signature that this group is involved in hydrogen bonding. The 
IRMPD spectra of cis-[Pt(NH3)2(A)Cl]
+ 
are consistent with the presence of two major 
isomers, PtAN3 and PtAN1, where Pt is bound to the N3 and N1 positions of native 
adenine, respectively.  
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Introduction. 
 
Cis-diamminedichloroplatinum(II), commonly known as cisplatin (cis-[Pt(NH3)2Cl2]), is a 
widely-used anticancer drug
 
that has been particularly successful in treating different types 
of tumors (lung, ovarian, testicular, head, and neck).
1
 Since its discovery some 40 years 
ago,
2,3
 many efforts have been devoted to understand the mechanisms associated with its 
antitumor activity,
4,5 
which are nowadays quite well established. The primary target of 
cisplatin is genomic DNA, and more especially the N7 position of guanine bases. Cisplatin 
enters the cell by passive diffusion through the cell membrane. The biologically active 
substrate, namely cis-[Pt(NH3)2(H2O)Cl]
+
 is then formed within the cell, a process promoted 
by the low chloride concentration inside the cell. It interacts with a guanine residue at the 
N7 position, thereby generating the monofunctional adduct by loss of water. In a subsequent 
step, the second chlorine atom is expelled and coordination to the N7 position of an adjacent 
purine results in what is called an intrastrand cross-link.
6,7
 These intra-strand cross-links are 
mainly 1,2-d(GpG) and to a lesser extent 1,2-d(ApG). 1,2-intrastrand cross-links structurally 
distort the DNA duplex
8,9 
 and ultimately lead to the genotoxicity and antitumor activity.   
In spite of the clinical success of cisplatin, side effects, natural and acquired resistance of 
patients toward the drug have motivated searches for structurally and/or functionally 
analogous alternatives. Unfortunately, finding analogous compounds that outperform 
cisplatin has proved to be difficult. Thousands of platinum compounds have indeed been 
synthesized during more than four decades. However, only few new agents such as 
oxaliplatin, carboplatin, and nedaplatin
5
 have been registered worldwide and entered clinical 
practice. Although there is no doubt that a Pt−N7 bond forms during initial attack, the exact 
structure of the monofunctional adduct is not well known.  In this context, a better 
understanding at the molecular level of the interactions between the Pt and DNA building 
blocks is thought to be helpful in establishing a new strategy to design cisplatin analogues. 
 4 
Such information may be accessible through gas-phase studies, and the present paper is the 
first of a series of articles dealing with the experimental structural characterization of 
cisPt/DNA components in the gas phase. We opted for a strategy based upon the gradual 
increase of the size of the nucleic acid building blocks. We presently report the structural 
characterization of gas-phase complexes arising from the interaction between cisplatin and 
the two nucleobases known to be involved in cross-links, namely guanine and adenine. 
To perform this study, we combined tandem mass spectrometry experiments with 
theoretical DFT calculations, and also recorded the IRMPD (Infrared Multiple Photon 
Dissociation) spectra of the ESI-generated complexes. IRMPD spectroscopy of mass-
selected ions is now established as a powerful approach for the structural characterization of 
gaseous ions
10-15
 and notably nucleotides,
16
 and has been successfully applied to metal 
ion/biomolecules systems.
12,17-32
 This ion spectroscopy is often termed “action 
spectroscopy” since resonant IR absorption cannot be directly probed due to the low ion 
density within mass spectrometers. Nevertheless, through the use of intense infrared sources, 
ion fragmentation can be induced by a multiple photon absorption process. Two distinct 
energy domains were considered. First, IRMPD spectra were recorded in the 950-1900 cm
-1
 
energy region by combining the CLIO (Centre Laser Infrarouge d'Orsay) free electron laser 
to a FT-ICR instrument. Infrared spectra in the 2900-3700 cm
-1
 frequency range were also 
recorded using an optical parametric oscillator (OPO) laser. This spectral range is of 
particular interest for probing the vibrational shifts associated to the NH and OH stretches 
involved in hydrogen bonds. 
 
Experimental  
2.1 Materials 
Cis-diamminedichloroplatinum(II) (cisplatin), 2′-deoxyadenosine-5′-monophosphate (5’-
dAMP), 2′-deoxyguanosine-5′-monophosphate (5’-dGMP) and water used in this work were 
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research grade products from commercial sources (Sigma-Aldrich s.r.l. Milan, Italy) and 
were used without any further purification. Stock aqueous solutions of cisplatin and of the 
two deoxynucleotides were prepared at 10
-3
M concentrations. In order to generate the 
complexes of interest in the gas phase, deoxynucleotides were used instead of the 
nucleobases given the poor solubility of the latter in any solvent. A 10
-4
M water solution of 
cisplatin and analyte (5’-dGMPor 5’-dAMP) were mixed together in the molar ratio of (1:1) 
and then allowed to react at room temperature for 24 h, to allow the formation of the 
different complexes before the analysis. In order to obtain the mixed complex [Pt(A)(G)(–
H)]
+
 (A:adenine; G:guanine), an aqueous solution with final concentration of 10
-4
M was 
prepared by mixing the three stock solutions of cisplatin, 5’-dGMP and 5’-dAMP in the 
molar ratio (1:1:1) and allowed to react for at least 20 days at room temperature prior to 
analysis.   
2.2 CID and IRMPD experiments 
 
Gaseous ions were generated using an electrospray ionization (ESI) source through direct 
infusion by a syringe pump. CID experiments at variable energy were carried out using a 
2000 Q-Trap instrument (Applied Biosystems), a commercial hybrid triple quadrupole 
linear ion trap mass spectrometer (Q1q2QLIT). Typical ESI conditions were a flow rate of 10 
l/min, a declustering potential set to 90V, and an entrance potential of 8 V. The ion of 
interest was mass-selected using Q1. CID experiments were performed in the quadrupole 
collision cell q2 at variable collision energies (Elab = 5 – 50 eV) with N2 as collision gas at a 
nominal pressure of 3.3  10-5 mbar. The dissociation product pattern was monitored by 
scanning QLIT using the enhanced mode operation where the ions, formed in collision cell 
q2, are trapped in QLit for 10 accumulation spectra in order to increase both the resolution 
and intensity. A certain extent of fragmentation products, which did not appreciably change 
in the early steps of increasing Elab, was observed even at the lowest Elab value of 5 eV that 
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was allowed by the instrumental parameters. This early dissociation is ascribed to the 
presence of collision gas not only in q2 but also in the region between Q1 and q2.
33-35
 This 
explanation is supported by the pressure dependence of the relative fraction of these 
products. Quantitative threshold information is not directly amenable.
27,33,36,37
 However, for 
a comparative analysis of the energy-dependent CID experiments, the collision energies 
were converted to the center-of-mass frame ECM=[m/(m+M)]Elab, in which m and M are the 
masses of the collision gas and of the ion, respectively. Relative abundances of fragment 
ions display an energy dependence that can be modelled by a sigmoid function and 
phenomenological appearance energies may be derived from linear extrapolation of the rise 
of the sigmoid curves to the baseline.
33,38,39
 
IRMPD experiments on cis-[Pt(NH3)2(A)Cl]
+
 and cis-[Pt(NH3)2(G)Cl]
+
 ions have been 
performed in two spectral regions, namely 950-1900 cm
-1
 and 2900-3700 cm
-1
, using two 
different IR radiation sources, the free electron laser (FEL) at the Centre Laser Infrarouge 
d’Orsay (CLIO) facility and an Optical Parametric Oscillator/Amplifier (OPO/OPA) laser 
system at the Università di Roma “La Sapienza”, respectively. The FEL radiation is 
generated by a 10-50 MeV electron linear accelerator and is delivered in 8 s-long 
macropulses at a repetition rate of 25 Hz, each containing few hundred micropulses (few 
picoseconds long). Typical macropulse energies are 40 mJ. Ions were irradiated for 250 ms 
to 1 sec with the IR FEL radiation. For the present study, the FEL was operated at 45 MeV 
in order to optimize the laser power in the frequency region of interest. The laser 
wavelength profile was monitored at each reading with a monochromator associated with a 
pyroelectric detector array (spiricon). 
FEL-based experiments were performed using a hybrid FT-ICR tandem mass spectrometer 
(APEX-Qe Bruker) equipped with a 7.0 T actively shielded superconducting magnet and a 
quadrupole-hexapole interface for mass-filtering and ion accumulation, under control by the 
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commercial software APEX 1.0. This particular experimental setup has already been 
described in details elsewhere.
40
 cis-[Pt(NH3)2(A)Cl]
+
 and cis-[Pt(NH3)2(G)Cl]
+
 ions were 
mass-selected in the quadrupole and accumulated in a hexapole containing argon buffer gas 
for 0.5 sec for collisional cooling. Ions are then pulse-extracted towards the ICR cell where 
mass-selection of the complexes is performed. They are then irradiated with IR light, after 
which the resulting ions are mass-analyzed. 
An Optical Parametric Oscillator/Amplifier (OPO/OPA) (LaserVision) coupled to a Paul 
ion trap tandem mass spectrometer Esquire 6000+ (Bruker Inc), has been employed to 
explore the 2900-3700 cm
-1
 spectral region of the different species under study. This 
parametric converter is pumped by a non seeded Nd:YAG laser (Continuum Surlite II) 
operating at 10Hz repetition rate. The typical pulse width of this pump laser is 4-6 ns with 
output pulse energy of 600 mJ at 1064 nm. The OPO/OPA laser is tunable within 2800-
4000 cm
-1
 and tunability is achieved by angle fine adjusting of OPO and OPA crystals 
simultaneously. The angle tuning is controlled precisely using software controlled stepping 
motors. The typical output energy from the OPO/OPA laser was 20 mJ/pulse in the 
investigated spectral range with 3-4 cm
-1
 bandwidth. IR beam focussing is performed to 
achieve better overlap with the trapped ion cloud. In the trap, ions were accumulated for 5-
50 msec prior to IR irradiation. Multistage mass spectrometry is performed using the 
standard Bruker Esquire Control (v5.2) software. The typical irradiation time used in the 
experiment is 0.5 to 2 sec. The irradiation time is controlled using an electromechanical 
shutter synchronized precisely with the mass spectrometer. 
The IRMPD spectrum is obtained by plotting the photofragmentation yield R (R = -
ln[Iparent/(Iparent + ΣIfragment)] where Iparent and Ifragment are the integrated intensities of the mass 
peaks of the precursor and of the fragment ions, respectively) as a function of the frequency 
of the IR radiation.
41
 A recent study
42
 has demonstrated that this data treatment allows a 
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better comparison with calculated infrared absorption spectra and a better spectral resolution 
than other analysis methods such as recording a depletion spectrum or calculating a 
photodissociation yield.  
2.3 Computational Details  
Molecular orbital calculations were carried out using the B3LYP
43,44
 density functional, as 
implemented in the Gaussian-03 set of programs.
45
 The different forms considered have 
been optimized with the 6-311G** basis set, without any symmetry constraint. In order to 
describe the metallic center, we used the Los Alamos effective core potential (ECP) in 
combination with the LACV3P** basis set. 
46-48
 Harmonic vibrational frequencies were 
estimated at this level to characterize the stationary points as local minima or saddle points, 
and to estimate the zero-point vibrational energy (ZPE) corrections. In the perspective of 
studying bigger systems, B3LYP/6-31G** calculations have been also performed, Pt being 
described either with the SKBJ ECP+basis sets 
49
or the LANL2DZ approach. 
46-48
 It turned 
out that both the relative energies and vibrational spectra are similar, regardless of the 
pseudo-potential and basis sets used to perform the calculations. 
The infrared absorption spectra of the various structures were calculated within the 
harmonic approximation. As far as the positions of the absorption bands are concerned, a 
scaling factor value of 0.974 has been chosen in the 950–1900 cm−1 region while a value 
0.957 is used in the 2900–3700 cm−1 frequency range. Finally, to be consistent with the 
experimental spectral resolution, the calculated absorption lines have been convoluted with 
a Gaussian profile of 15 cm
−1
 FWHM (full width at half maximum) in the 950–1900 cm−1 
region, while a FWHM of 5 cm
−1
 was used for the 2900–3700 cm−1 frequency range. As a 
final point, the relative stability in solution of the various complexes has also been evaluated 
by using the Polarized Continuum Model (PCM) in order to take into account the water 
solvent. 
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Throughout this paper total energies are expressed in Hartrees and relative energies in kJ 
mol
-1
. For the sake of simplicity, the basis set used for Pt will be referred to as 6-311G**. 
Detailed geometries (Cartesian coordinates) of all the structures mentioned in this paper are 
available from the authors upon request. 
 
3.Results and Discussion 
 
3.1 Collision-induced dissociation experiments 
Formation of both cis-[Pt(NH3)2(A)Cl]
+
 and cis-[Pt(NH3)2(G)Cl]
+
 adducts results from the 
reaction taking place in a solution containing cisplatin together with either 2′-
deoxyadenosine-5′-monophosphate (5’-dAMP) or 2′-deoxyguanosine-5′-monophosphate 
(5’-dGMP) during a 24 h incubation period. In this process, likely steps comprise the 
hydration of cisplatin through the displacement of a chloride ion by a water molecule and 
hydrolysis of the deoxynucleotide. It may be noted that this indirect way of obtaining A and 
G adducts using a solution containing the corresponding deoxynucleotide as a source of the 
nucleobase overcomes the problem of the scant solubility of the native nucleobase. The 
complexes of interest are formed together with other species containing both (5’-dGMP) or 
(5’-dAMP) or their derivatives bound with cisplatin ions. When the 1:1 mixture of cisplatin 
and 5’-dGMP is analyzed after 24 h incubation time, under usual ESI conditions, an intense 
cluster signal is observed at m/z 414-420 consistent with the formation of cis-
[Pt(NH3)2(G)Cl]
+ 
(Figure S1a of the supporting information).
50
 The simultaneous presence 
of one chlorine and one platinum atom in the ion yields a characteristic isotopic pattern, 
easily distinguishable from any one corresponding to Pt-complexes devoid of a chlorine 
atom. Under similar conditions, the corresponding cis-[Pt(NH3)2(A)Cl]
+
 complex (m/z 398-
404) is formed, as evidenced in Figure S1b. 
The cis-[Pt(NH3)2(G)Cl]
+ 
adduct ions have been examined by collision-induced dissociation 
(CID) at variable collision energy, in a hybrid triple quadrupole linear ion trap mass 
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spectrometer. The CID spectra were recorded for the selected precursor ion at m/z 415, 
holding 
195
Pt and 
35
Cl isotopes. The variation of the relative abundances of both precursor 
and fragment ions with respect to the center-of-mass collision energy (ECM) is given in 
Figure S2 of the supporting information. As can be seen from Figure S2, the CID spectrum 
of the cis-[
195
Pt(NH3)2(G)
35
Cl]
+
 ion (m/z 415) exhibits a primary fragment at m/z 398 
associated with the loss of one molecule of ammonia. One may note that this fragment ion is 
already present at the lowest collision energy. Four ions are also detected at higher ECM, 
namely m/z 381, 353, 317 and 152. These fragmentations can be ascribed to subsequent 
processes originating from the ion at m/z 398.
50
 The fragment ion detected at m/z 381 
corresponds to loss of the second ammonia molecule, while the ion at m/z 353 is due to the 
combined elimination of NH3 and CO. The fragment ion at m/z 317 may be attributed to the 
elimination of HCl from m/z 353 while the ion detected at m/z 152 corresponds to 
protonated guanine GH
+
. 
Likewise the CID of the adenine complex, cis-[Pt(NH3)2(A)Cl]
+
, showed similar 
characteristics. Again, the monoisotopic ion at m/z 399 containing 
195
Pt and 
35
Cl has been 
mass-selected as precursor ion for CID studies. The variation of the ion intensity of both 
precursor and fragment ions as a function of ECM is provided in Figure S3 of the supporting 
information. The MS/MS spectrum of the cis-[Pt(NH3)2(A)Cl]
+
 complex is characterized by 
two main dissociation processes. As observed from the guanine complex, the first 
dissociation product corresponds to the loss of ammonia, yielding the ion at m/z 382. The 
second one at m/z 346 is due to the elimination of a HCl molecule. Three additional 
fragment ions are also detected, which arise from higher energy processes following the 
primary loss of NH3. Elimination of a second molecule of ammonia leads to the m/z 365 ion. 
The species detected at m/z 329 may be attributed to loss of both ammonia and hydrochloric 
acid whereas the ion at m/z 136 corresponds to protonated adenine. 
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From these comparative CID experiments, in the case of cis-[Pt(NH3)2(G)Cl]
+
 ion one may 
envision the presence of a hydrogen bond between a molecule of ammonia of the cisplatin 
moiety and the guanine carbonyl oxygen, that might account for the fragment ion generated 
at m/z 353 by the simultaneous loss of ammonia and CO, that is peculiar to this complex. 
Similarly, the concomitant loss of NH3 and HCl from the cis-[Pt(NH3)2(A)Cl]
+
 adduct may 
suggest the presence of a hydrogen bond between a N-H group of adenine and the Pt-bound 
chlorine.
50
  
To gain a qualitative idea of the energy involved in cisplatin bonding to either adenine or 
guanine, energy-dependent CID experiments have been performed on ions generated by the 
loss of the first ammonia molecule. In fact both ions are found to yield the respective 
protonated nucleobase by CID. The energy-dependent CID of [Pt(NH3)(G)Cl]
+ 
is displayed 
in Figure 1a.  
It is worth mentioning that all secondary fragments observed in the MS/MS spectra of cis-
[Pt(NH3)2(G)Cl]
+ 
 are present in these CID experiments. Linear extrapolation of the rise of 
the sigmoid curve yields a phenomenological threshold energy (EPT) of 1.55 ± 0.2 eV (148 
± 20 kJ mol
-1
) for the appearance of GH
+
. Although the breaking of the cisplatin-guanine 
bond requires a higher energy compared to the other fragments, protonated guanine 
becomes the principal fragment with increasing ECM. The energy-dependent CID of 
[Pt(NH3)(A)Cl]
+ 
is showed in Figure 1b. The value of the phenomenological threshold 
energy for the appearance of the protonated adenine ions is 1.38 ± 0.2 eV (132 ± 20 kJ mol
-
1
). Although this extrapolation does not provide by any means a direct measure of the 
threshold energy for dissociation, it suggests though that cisplatin is more strongly bound to 
guanine than to adenine. 
As a last piece of information, the mixed complex [Pt(A)(G)(-H)]
+
 was also studied by CID. 
Its formation is not trivial. An aqueous solution containing cisplatin, (5’-dGMP) and (5’-
 12 
dAMP) in 1:1:1 molar ratio needs to be stored at room temperature for more than 20 days in 
order for the reaction to proceed, yielding the mixed adduct observed by ESI-MS. The full 
scan ESI spectrum of this mixture is given in Figure S1c. The solution thus prepared 
showed two main cluster ions, the first centered around m/z 497 corresponding to adduct 
[Pt(NH3)(A)(G)(-H)]
+
 and the other detected around m/z 480 which corresponds to 
[Pt(A)(G)(-H)]
+
. We focused our attention on the latter complex which may yield an insight 
about whether platinum is preferentially bound to either adenine or guanine. The presence 
of ammonia in the former complex may induce complicating effects arising from the 
possibility of hydrogen bonding interactions between NH3 and the nucleobases. CID 
experiments at variable CE have been conducted on the ion at m/z 480, which contains the 
195
Pt isotope. Two different dissociation channels were observed, leading to protonated 
adenine and protonated guanine, as displayed in Figure 1c. Phenomenological threshold 
energy (EPT) values of 1.17 ± 0.20 eV (112 ± 20 kJ mol
-1
) and of 1.46 ± 0.20 eV (140 ± 20 
kJ mol
-1
) are deduced for the fragmentation processes leading to protonated adenine and 
protonated guanine, respectively. In the event that the energetics of the competitive 
fragmentation processes were governed by the relative proton affinity of the two bases, a 
bias could be expected for the formation of protonated guanine. In fact the gas-phase proton 
affinity (PA) of guanine (959.5 kJ mol
-1
)
51
 is higher than the PA of adenine (942.9 kJ mol
-
1
)
51
. Consequently, the CID data would rather suggest that in the [Pt(A)(G)(-H)]
+
 complex 
guanine is more strongly bound than adenine. Thus, one may argue that the preference of 
cisplatin toward guanine may be related not only to the strong hydrogen bond that can be 
established between a hydrogen atom of the ammonia ligand and the oxygen atom of 
guanine (a stronger hydrogen bond than the one involving either N atom of adenine as 
electron density donor), but also to intrinsic features of the Pt bonding, favoring guanine 
relative to adenine. 
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3.2 IRMPD spectroscopy of cis-[Pt(NH3)2(G)Cl]
+ 
complex 
The main purpose of this work is to elucidate and characterize the structure of the cis-
[Pt(NH3)2(G)Cl]
+
 and cis-[Pt(NH3)2(A)Cl]
+ 
ions
 
taken as simple models of mono-adducts 
between cisplatin and DNA, by IRMPD spectroscopy. To this end, IRMPD spectra were 
recorded in two different spectral regions, in the so-called fingerprint region (950 – 1900 
cm
-1
), using the beamline of the IR-FEL at CLIO, and in the X-H (X = C, N, O) stretching 
region (2900-3700 cm
-1
), using a tabletop IR OPO/OPA laser coupled to a modified Paul 
ion-trap. 
In order to extract structural information, the IRMPD spectrum of cis-[Pt(NH3)2(G)Cl]
+
 ions 
is compared with the calculated IR spectra of potential candidate geometries. The optimized 
structures for isomers corresponding to the cis-[Pt(NH3)2(G)Cl]
+
 general formula have been 
obtained by performing B3LYP/6-311G** calculations and are presented in Figure 2 (all the 
structures obtained in the present work are gathered in Figures S8 and S9 of the supporting 
information).  
Guanine has three possible binding sites with the transition metal, the two nitrogen atoms 
N3 and N7, and the carbonyl oxygen atom (O6).
52
 Insights into the structural features of 
cisplatin interaction with guanine have been obtained in recent theoretical work. The N7 
position of guanine was identified as the preferred platination target.
53
 The optimized 
geometries of cis-[Pt(NH3)2(G)Cl]
+ 
presented in Figure 2 illustrate the three different 
binding sites of guanine. Binding to N7 gives rise to two conformers, as also illustrated 
recently,
53
 named PtGN7-1, where one hydrogen atom of an ammonia ligand interacts 
through a hydrogen bond with the carbonyl oxygen at the C6 position, and PtGN7-2 where 
the plane defined by the metal in its square planar coordination is perpendicular to the 
guanine plane. In fact the latter structure was actually a transition state at the B3LYP/6-
31G** level (one negative eigenvalue).
53
 A similar result is obtained with the present level 
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of calculation. Without any constraint, PtGN7-2 spontaneously evolves towards PtGN7-1. 
The coordination to O6 yields also two different conformers differing by the orientation of 
the (NH3)2Pt(Cl) group with respect to the guanine ligand. In the first one, PtGO-1, a weak 
hydrogen bond is found between the hydrogen in N1 and the chloride ligand. In the second 
one, PtGO-2, a hydrogen bond is established between one hydrogen of an ammonia ligand 
and N7. In another isomer given in Figure 2, PtGN3, (NH3)2Pt(Cl) is bound to N3. As 
shown by the relative free energies at 298 K reported in Figure 2, the global minimum 
corresponds to the PtGN7-1 complex. The preferred binding site of guanine is N7, yielding 
a structure that is stabilized by a strong hydrogen bond. When this hydrogen bond is not 
allowed, the ensuing conformer PtGN7-2 is only slightly more stable that the O-coordinated 
structures (PtGO-1 and PtGO-2). Globally, the two latter structures are less stable than 
PtGN7-1 by more than 40 kJ mol
-1
.  
Finally, the platination onto the N3 position yields the least stable isomer, placed about 94 
kJ mol
-1
 above PtGN7-1. Examination of PtGN3 indicates that the guanine moiety is no 
longer planar. Consequently, coordination to the N3 atom induces an important distortion of 
the aromatic ring from planarity that destroys much of the resonance delocalization and is 
associated to a high-energy species. 
In the FT-ICR mass spectrometer, it was possible to isolate the whole isotopic cluster 
corresponding to the cis-[Pt(NH3)2(G)Cl]
+ 
complex at m/z 414-418, submitting it to the 
IRMPD experiment. The fragmentation of cis-[Pt(NH3)2(G)Cl]
+ 
upon irradiation by IR 
photons in resonance with an active vibrational mode in the fingerprint region yields the 
same fragment ions as previously observed in the CID experiments, that is loss of one NH3 
(cluster at m/z 397-401), loss of two ammonia molecules (cluster at m/z 380-384) and loss of 
two NH3 and CO (cluster at m/z 352-356). On the other hand, protonated guanine (m/z 152) 
is not detected as photofragmentation product (Figure S4 of the supporting information). In 
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the X-H stretching region (2900-3700 cm
-1
) the only photofragment observed in the IRMPD 
process is [Pt(NH3)(G)Cl]
+
 (cluster at m/z 397-401). 
The IRMPD spectrum of cis-[Pt(NH3)2(G)Cl]
+
 in the 950–1900 cm−1 range is plotted in 
Figure 3a together with the IR spectra calculated for the stable species presented in Figure 2.  
The experimental spectrum of cis-[Pt(NH3)2(G)Cl]
+
 (Figure 3a) shows four pronounced 
features at 1289, 1597 1637 and 1718 cm
−1
 and other weaker bands appear at 1119, 1178, 
1213, 1330, 1350, 1428, 1488 and 1536 cm
−1
. 
The main features in the experimental spectrum are nicely matched by the computed 
spectrum of the isomer PtGN7-1. Relying on the typically good agreement between the 
IRMPD spectrum and the linear IR spectrum of the sampled species obtained by DFT 
calculations, the vibrational modes of cis-[Pt(NH3)2(G)Cl]
+
 can be assigned as described in 
Table S2 where the experimental IRMPD features are listed together with the IR bands 
calculated for the most stable isomer PtGN7-1. The IR bands calculated for other isomers 
together with the associated vibrational modes are listed in Tables S3-S5 in the supporting 
information. 
The IRMPD feature at 1289 cm
-1
 is particularly broad and presents two shoulders at c.a. 
1330 and 1350 cm
-1
. This signal comprises the umbrella bending modes of the two NH3 
ligands. Interestingly, the umbrella mode for the ammonia ligand involved in H-bonding 
with the carbonyl oxygen in PtGN7-1 (denoted NH3
 
while the other ammonia is called 
N'H3) is calculated at 1318 cm
-1
, which may account for the shoulder observed 
experimentally at 1330 cm
-1
. The umbrella motion of the N'H3 ligand, trans to G, presents a 
value, at 1301 cm
-1
. Finally, the shoulder at 1350 cm
-1
 on the high frequency side of the 
IRMPD band at 1289 cm
-1
 can be assigned to the in-plane bending of H-N1. 
The three strong bands at 1597, 1637 and 1718 cm
-1
 are associated to the NH2 scissoring, 
the H2N-C2 stretching and the C6=O stretching modes calculated at 1597, 1637 and 1706 
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cm
-1
 respectively. It is important to note that the C=O stretching is red-shifted with respect 
to an unperturbed C=O stretching vibration expected at ca. 1810 cm
-1
 as observed in isomer 
PtGN3. This effect can be explained by the formation of a Hydrogen bond that weakens the 
double bond character, and also by the proximity of the platinum ion. Note that the direct 
binding of the platinum ion to the O6 center further reduces the double bond character of 
C6=O, and in fact its absorption is red-shifted to 1656 cm
-1 
(PtGO-1 structure, Table S4). 
Conversely, the H2N-C2 stretching mode is blue-shifted due to the partial double-bond 
character of the N-C2 bond, as attested by the sp
2
 hybridization of the NH2 group. The other 
minor absorptions can be assigned to vibrational modes of the purine ring and are reported 
in detail in Table S2. As a further remark on the IRMPD spectrum of cis-[Pt(NH3)2(G)Cl]
+
 
in the fingerprint region, one may note that recording the spectrum with an attenuated beam 
(thus reducing saturation effects) brings the relative band intensities in better agreement 
with the calculated IR spectrum of PtGN7-1. 
Examination of Figure 3 shows that the IR signatures of PtGO-1 or PtGO-2 forms are also 
globally consistent with the experimental spectrum, and consequently, cannot be rigorously 
excluded. However, these two structures are significantly less stable than PtGN7 in the gas 
phase. In addition, PCM calculations were also carried out onto these complexes in order to 
get some insight about the effect of the solvent. These calculations show that the energy gap 
between these three forms should be further increased in water, which is consistent with the 
prominent formation of PtGN7 during the ESI process, if one considers that the ion 
population will reflect the Boltzmann equilibrium distribution in water.  
The cis-[Pt(NH3)2(G)Cl]
+
 ions have also been investigated in the region from 2900 to 3700 
cm
−1
. As shown in the lower panel of Figure 4, cis-[Pt(NH3)2(G)Cl]
+ 
presents numerous 
absorptions, the four major ones being observed at 3417, 3437, 3453 and 3474 cm
-1
.  
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Other weaker but still significant features are detected at 3054, 3153, 3340, 3387, 3537 and 
3559 cm
-1
. Once again, on comparing with the calculated IR spectra convoluted with a 
Gaussian profile of 5 cm
−1
 (FWHM) reported in Figure 4b-e, one finds a generally good 
agreement between the IRMPD spectrum of cis-[Pt(NH3)2(G)Cl]
+
 and the IR spectrum of 
isomer PtGN7-1. The main feature at 3474 cm
-1
 can be assigned to the N9-H stretching 
mode expected at 3470 cm
-1
. The absorption at 3417 cm
-1
 corresponds to the N1-H 
stretching mode calculated at 3421 cm
-1
. The two bands at 3453 cm
-1
 and 3559 cm
-1
 are 
consistent with the symmetric and antisymmetric stretching modes of NH2 expected at 3451 
and 3567 cm
-1
, respectively, for PtGN7-1. The two bands at 3340 and 3387 cm
-1
 are due to 
antisymmetric stretching modes of the NH3 ligands. The first one comprises two absorptions 
calculated at 3345 and 3353 cm
-1
 and the second one is a convolution of modes active at 
3393 and 3401 cm
-1
. The feature at 3153 cm
-1
 is compatible with the C8-H stretching mode 
expected at 3148 cm
-1
. The experimental IRMPD spectrum of cis-[Pt(NH3)2(G)Cl]
+
 shows a 
broad absorption around 3054 cm
-1
 that may be assigned to the NH stretching of the N-H 
bond involved in hydrogen bonding with the carbonyl oxygen of guanine, calculated at 3038 
cm
-1
. Although the calculated intensity for this stretching mode involving hydrogen-bonding 
is high, the experimental band is rather weak. Previously, such simultaneous red-shifts and 
broadening effects of stretching vibrations of X-H (X=N,O) groups involved in a hydrogen 
bond have been observed for water solvated clusters
54
, solvated amino acids
55
 or 
nucleobases.
56,57
, and lactic ester derivatives.
58
 One possible explanation may lie in the 
anharmonicity of this mode and the ensuing low IRMPD efficiency. However the presence 
of these two latter features is remarkable. To our knowledge this is one of the first example 
of NH vibration involved in hydrogen bonding revealed by IRMPD spectroscopy using an 
OPO/OPA laser, in the absence of a loosely bound tag such as a solvating water molecule.
54
 
It is also difficult to observe C-H stretching modes for covalently bonded species with the 
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present experimental apparatus. Typically, these modes are weakly active and at the same 
time the laser power at wavenumbers lower than 3100 cm
-1
 is appreciably decreasing.  
It may be noted that the experimental spectrum of cis-[Pt(NH3)2(G)Cl]
+
 shows two features 
that do not find a counterpart in the calculated IR spectrum of isomer PtGN7-1, namely the 
bands at 3437 and 3537 cm
-1
. These signals can be compared with two absorptions bands 
computed for the PtGN7-2 conformer, at 3435 and 3553 cm
-1
, respectively, corresponding 
to the symmetric and antisymmetric stretching mode of NH2 as reported in Figure S5 on the 
Supporting Information. Considering the high relative free energy of PtGN7-2 with respect 
to PtGN7-1 (higher than 42 kJ mol
-1
) and given the fact that this structure is actually a 
transition state on the potential energy surface, it is somewhat difficult to conceive the 
presence of the PtGN7-2 in any significant amount from the ESI process. More probably, 
these two relatively minor absorptions may arise from a conformer that has been missed in 
the conformational survey. Whatever the right explanation could be, the observed features 
appear consistent with an isomer characterized by cis-[Pt(NH3)2Cl]
+ 
binding to guanine in 
N7 position. 
 
3.3 IRMPD spectroscopy of cis-[Pt(NH3)2(A)Cl]
+
 complex 
The last issue addressed in this work regards the structure of the cis-[Pt(NH3)2(A)Cl]
+
 
complex generated in the water solution. Contrary to guanine, the three possible binding 
sites of adenine, namely N1, N3 and N7, show a quite similar affinity for the platinum 
moiety. The calculated binding affinity order for [Pt(NH3)3]
2+
 was N3 (368.2 kJ mol
-1) ≥ N1 
(364.0 kJ mol
-1
) > N7 (338.9 kJ mol
-1
).
52
 In DNA, cisplatin binds the adenine residue 
especially onto N7 and N1 positions. However, dealing with the nucleobase alone, the three 
positions are all potentially available for the cisplatin interaction. Furthermore, previous 
studies have demonstrated that adenine can tautomerize in water and polar solvents.
59,60
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NMR measurements in water have established the coexistence of two amino tautomers of 
adenine, namely the N9-H tautomer (so-called native adenine, predominant by a factor of 
ca. 4) and the N7-H structure.
61
 The presence of the N3-H form, though in only minor 
amount, has been detected exclusively in DMSO solvent.
59
 For this reason, in addition to 
the conventional binding sites of canonical adenine, complexes of (NH3)2Pt(Cl)
+
 with the 
N7-H tautomers have also been considered as potential candidates for the cis-
[Pt(NH3)2(A)Cl]
+ 
complex obtained in aqueous solution. Figure 5 displays the optimized 
structures of the most stable conformer for plausible cis-[Pt(NH3)2(A)Cl]
+
 isomers as 
obtained at the B3LYP/6-311G** level. 
The PtAN3 structure illustrates the most stable conformer obtained by the interaction of the 
(NH3)2PtCl
+ 
unit with the N3 position of native adenine. The chloride ion is pointing 
towards the hydrogen atom in N9. The distance between the two atoms (2,723 Å) is too 
large to allow proper H-bonding, however it may provide stabilization by an electrostatic 
effect. The binding to N1 and N7 positions of adenine in the native form yields structures 
PtAN1 and PtAN7, respectively (Figure 5). In the N7-H amino tautomer of adenine, 
binding to N3 yields PtAN3N7t also shown in Figure 5. In this structure, a hydrogen bond 
is established between a hydrogen of an ammonia ligand and N9. The PtAN9N7t form, 
obtained by the coordination of Pt(NH3)2Cl
+
 to N9 of the N7-H tautomer, also allows 
hydrogen bonding between a hydrogen of an ammonia ligand and N3.  
Focusing on the three isomers of the cis-[Pt(NH3)2(A)Cl]
+
 complexes involving native 
adenine, binding to N3 gives rise to the lowest energy isomer. In agreement with previous 
calculations,
52
 PtAN1 is only 5.3 kJ mol
-1
 less stable than PtAN3 and the coordination to 
N7 (PtAN7), is less favoured by 13.3 kJ mol
-1
. Unexpectedly, the two structures of cis-
[Pt(NH3)2(A)Cl]
+ 
involving tautomer N7-H are lower in energy with respect to PtAN3. This 
result may appear surprising because native adenine is calculated to be the most stable 
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tautomer.
59,62
 A probable explanation lies in the presence of a hydrogen bond in both 
PtAN3N7t and PtAN9N7t complexes, providing additional stabilization to these species. 
The lowest energy isomer is thus PtAN9N7t, 13.7 kJ mol
-1 
more stable than PtAN3. On the 
other hand, PCM calculations suggest PtAN3 as the most stable structure in solution, the 
energy difference between the various forms being strongly reduced (Figure 5).  
As in the case of cis-[Pt(NH3)2(G)Cl]
+
,
 
the whole isotopic cluster corresponding to the cis-
[Pt(NH3)2(A)Cl]
+ 
complex at m/z 398-404 was isolated prior to starting the IRMPD 
experiment. The photofragmentation efficiency observed for cis-[Pt(NH3)2(A)Cl]
+ 
was 
lower than in the case of cis-[Pt(NH3)2(G)Cl]
+ 
in both
 
spectroscopic regions investigated 
(resulting in smaller R values).  
In the fingerprint region there are only four photofragment ions observed, as reported in 
Figure S6 in the supporting material. The principal fragment ion is the one from loss of one 
NH3 (cluster at m/z 381-387) and a second abundant one is the protonated adenine at m/z 
136. A less abundant photofragment is due to loss of one ammonia plus a hydrogen chloride 
molecule (cluster at m/z 345-347). This ion tends to add a molecule of water, present as 
unavoidable contaminant in the Paul trap, (cluster at m/z 365-367). The same ionic products 
are observed for photodissociation in the X-H stretching region (2900-3700 cm
-1
). It should 
be noted that, in contrast with the behavior displayed by cis-[Pt(NH3)2(G)Cl]
+
, protonated 
adenine is always present as photofragment. This fact is in line with a stronger binding of 
guanine with respect to adenine in platinum complexes.  
The IRMPD spectrum of cis-[Pt(NH3)2(A)Cl]
+ 
recorded in the 1000–1900 cm-1 spectral 
range is reported in the lower panel of Figure 6, together with the calculated IR spectra of 
the species shown in Figure 5.  
Even using a longer irradiation time (1 sec instead of 250 ms), the photofragmentation 
process is considerably less extensive than that observed for cis-[Pt(NH3)2(G)Cl]
+
. Three 
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main features are present in the spectrum of cis-[Pt(NH3)2(A)Cl]
+
 at 1300, 1430 and 1658 
cm
-1
, respectively. The latter absorption is preceded by a shoulder at 1610 cm
-1
. Other 
weaker bands are found at 1120, 1208, 1256, 1361 and 1494 cm
-1
. Apparently, all the 
calculated spectra displayed in Figure 6 seem to be very similar to each other and well 
related to the experimental one. However, some minor differences in the calculated spectra 
may allow an insight about the sampled ion population. At first sight, one may exclude the 
presence of PtAN7, in the cis-[Pt(NH3)2(A)Cl]
+
 experimental ion population. The band 
calculated at about 1602 cm
-1
, combining two highly active vibrational modes at 1594 and 
1616 cm
-1
, is notably shifted with respect to the experimental one found at 1658 cm
-1
. In 
contrast, all other four species taken in consideration present a strong feature at nearly 
constant frequency, namely at 1641, 1638, 1639 and 1642 cm
-1
 for PtAN3N7t, PtAN9N7t, 
PtAN1 and PtAN3, respectively. As another criterion helping to assign the proper structure, 
one may consider the gap between this feature and the band preceding it. In the two isomers 
of tautomer N7-H, the difference in the band position is 76 cm
-1
 for PtAN3N7t (at 1565 and 
1641 cm
-1
) and 67 cm
-1
 for PtAN9N7t (the two bands are predicted at 1571 and 1638 cm
-1
). 
These two values are significantly greater than the gap observed experimentally (48 cm
-1
), 
rather disproving the presence of these two species in relevant amount in the sampled cis-
[Pt(NH3)2(A)Cl]
+
 ions. The calculated spectrum of PtAN3 gives the best fit with the 
experimental spectrum. The gap between the two absorptions in the higher frequency region 
of the mid-IR spectrum is 55 cm
-1
, in quite good agreement with the experimental value of 
48 cm
-1
. The band at 1361 cm
-1
 finds a counterpart in the calculated mode at ca. 1355 cm
-1
, 
associated with the convolution of two bands at 1341 and 1362 cm
-1
. There is also a good 
agreement with other features of the spectrum. Only two experimental IRMPD bands do not 
find a counterpart in the calculated spectrum of isomer PtAN3, the small absorption at 1494 
cm
-1
, as well as the band at 1208 cm
-1
, which, however, can be both observed in the 
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calculated spectrum of isomer PtAN1, at 1488 and 1206 cm
-1
, respectively. PtAN1 shows a 
separation of 45 cm
-1
 in the position of the two bands at around 1600 cm
-1
, in accord with 
the experimental spectrum. These findings suggest that the ionic adduct cis-
[Pt(NH3)2(A)Cl]
+
 under examination would be a mixture of both isomers PtAN3 and 
PtAN1. In addition, several argument are in favor of a minor, if any, contribution of 
complexes containing N7-H tautomers. First of all, as previously reported,
59,60 
native 
adenine is the major species in water solution, and PCM calculations suggest that the most 
stable cis-[Pt(NH3)2(A)Cl]
+
 complex (PtAN3), involves native adenine. Secondly, due to 
the poor solubility of adenine, an aqueous solution of 5’-dAMP rather than of adenine was 
used in the present study to generate cis-[Pt(NH3)2(A)Cl]
+
. Reported NMR measurements of 
AMP in water solution have found that this species, in contrast with adenine, does not 
tautomerize.
59
 One may therefore argue that in solution cis-[Pt(NH3)2(H2O)Cl]
+
 is reacting 
with 5’-dAMP and in the event of ion transfer to the gas phase during the electrospray 
process, direct N-glycosidic bond cleavage occurs, yielding native adenine-containing cis-
[Pt(NH3)2(A)Cl]
+
 ion. 
With these considerations in mind, the vibrational modes of cis-[Pt(NH3)2(A)Cl]
+
 can be in 
a first attempt assigned as described in Table S6, where the experimental IRMPD features 
are listed together with the IR bands calculated for PtAN3. Focusing on the main 
absorptions, the experimental band at 1300 cm
-1
 can be assigned to the umbrella mode of 
the ammonia ligands calculated at 1295 and 1310 cm
-1
. The principal feature at 1658 cm
-1
 
can be related to the combination of two vibrational modes, namely the NH2 scissoring and 
the C6-NH2 stretching, expected at 1642 cm
-1
. Finally, the shoulder at 1610 cm
-1
 may 
correspond to NH2 scissoring combined with ring deformation modes, computed at 1582 
and 1588 cm
-1
,
 
respectively. 
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To complete this study, the IRMPD spectrum of cis-[Pt(NH3)2(A)Cl]
+
 has also been 
recorded in the 3000–3700 cm-1 spectral range, using an irradiation time of 2 s and the full 
laser power in order to maximize the photofragmentation yield. As reported in the lower 
panel of Figure 7, the experimental IRMPD spectrum of cis-[Pt(NH3)2(A)Cl]
+
 presents three 
main absorptions at 3353, 3428 and 3477 cm
-1
 and two shoulders at 3375 and 3456 cm
-1
.  
The spectrum is consistent with the presence of both PtAN3 and PtAN1 isomers in the 
sampled cis-[Pt(NH3)2(A)Cl]
+ 
ion population, although some calculated IR bands of 
expected lower activity are missing in the experimental spectrum. The main feature at 3428 
cm
-1
 is in good agreement with the symmetric stretching of NH2 expected at 3430 cm
-1
 for 
PtAN3 isomer (Table 2). The large band at 3477 cm
-1
 can be assigned to a convolution of 
two vibrational modes of PtAN1 isomer, namely the N9-H stretching mode and the 
asymmetric stretching mode of NH2 calculated at 3469 and 3478 cm
-1
, respectively. The 
small hump at about 3456 cm
-1
 is compatible with the N9-H stretching mode of PtAN3 
estimated at 3440 cm
-1
. The absorption at 3353 cm
-1 
with a large shoulder at around 3375 
cm
-1
 corresponds to stretching modes of NH3 groups pertaining to both isomers, expected at 
3353, 3379, 3386 and 3382 cm
-1
 for PtAN3 and 3352, 3372, 3374 3392 and 3396 cm
-1
 for 
PtAN1. Regrettably, the calculated band at 3553 cm
-1
, which corresponds to the asymmetric 
stretching mode of NH2 of PtAN3 isomer, is not observed in the experimental spectrum. 
This missing band is not easy to explain, however it may be noted that this mode is very 
weak also in the experimental spectrum of cis-[Pt(NH3)2(G)Cl]
+
, which has a much better 
IRMPD response. Such a weak asymmetric NH2 stretch has already been observed for 
Li+/adenine/thymine complexes
28,29
 and protonated dimers of adenine.
63
  
A further experiment has finally demonstrated that the two main absorptions at 3428 and 
3477 cm
-1
 do not belong to a single structure, as it is the case for the calculated spectra of 
PtAN3N7t and PtAN9N7t. Two IRMPD spectra of cis[Pt(NH3)2(A)Cl]
+
 have been 
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recorded on the same day, the first one using a “fresh” solution (Figure S7a), where 
cisplatin and 5'-dAMP had been allowed to react for 24 h before the analysis, and the 
second one using an “old “ solution where the two substrates had been incubated for two 
week (Figure S7b). The result was revealing. The IRMPD spectrum of the “fresh” solution 
was identical to the one reported in Figure 7. The experimental spectrum of the “old” 
solution instead showed a noticeable reversal in the relative intensities of the two main 
peaks as reported in Figure S7. The band at 3428 cm
-1
 is now weaker and the feature at 
3477 cm
-1
 becomes the principal absorption. In our opinion, this fact is evidence that the 
two main bands pertain to at least two isomers. In fact, with a single isomer present, the 
same IRMPD spectrum should be recorded with characteristic band positions and 
intensities. This is indeed the case for cis-[Pt(NH3)2(G)Cl]
+
 complex, showing constantly 
high reproducibility in IRMPD spectra run on different solutions and different days. In the 
specific case of cis-[Pt(NH3)2(A)Cl]
+
, the inversion of the intensities of the two bands 
suggests a slow isomerization within the complex. Studying the mechanisms associated with 
this isomerization is beyond the scope of the present manuscript, and will be the subject of 
further investigation. Clearly, it is noteworthy to underline that all the other experiments 
reported in the present paper were done only with "fresh" solutions, and thus can be referred 
to the same ionic population.  
Certainly, the presence of N7-H tautomeric forms for the cis-[Pt(NH3)2(A)Cl]
+
 complex 
cannot be rigorously excluded, notably given their particular calculated stability both in 
solution and in the gas phase. As suggested by one of the referee, and as already nicely 
illustrated for peptides
64
, use of isotopic labeling with 
15
N, selectively introduced onto N7 
and N9 positions of 5'-dAMP, would provide useful information in order to definitely 
attribute the various N-H stretches (red-shifts), and would address the presence of isomeric 
forms, and especially tautomers. According to our DFT calculations, red-shifts of about 8-9 
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cm
-1
 should be observed for the N7-H and N9-H stretches. Unfortunately, these compounds 
are not easily available.  
Conclusions 
The aim of this study is to provide an accurate characterization of cis-[Pt(NH3)2(G)Cl]
+ 
and 
cis-[Pt(NH3)2(A)Cl]
+
, models of the monofunctional adducts between cisplatin and the 
nucleobases of DNA, using IR spectroscopy of ions directly performed in the cell of a 
mass spectrometer. Both the IR characterization and the computational results point to a 
covalent structure for the cis-[Pt(NH3)2(G)Cl]
+ 
where Pt is uniformly bound to the N7 atom 
of guanine. In particular, the feature found at 1718 cm
-1
 corresponding to the C=O 
stretching, notably red-shifted with respect to an unperturbed C=O stretching vibration, and 
the absorption at 3054 cm
-1
 pertaining the N-H stretching of the NH3 molecule involved in 
hydrogen bonding with the carbonyl oxygen of guanine are clear proofs of the existence of 
a strong hydrogen bond between the carbonyl group at the C6 position of guanine and the 
H atom of one NH3 ligand of cisPt in the Pt-guanine complex. 
The IRMPD spectra of cis-[Pt(NH3)2(A)Cl]
+ 
are consistent with the presence of two major 
isomers, PtAN3 and PtAN1, where Pt is bound in the N3, and N1 positions of native 
adenine, respectively.  
The preferred platinum coordination site on adenine seems to be N3, which is not observed 
in the cell because such site is located in the internal groove and not easily accessible at an 
intrastrand cross-linking. However, this feature may open the way towards new transplatin 
compounds with a conformation potentially allowing an intrastrand cross-link between the 
N7 position of guanine and N3 position of adenine. 
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Table and Figure caption  
 
Figure 1. Relative abundances of the precursor ion and fragment ions as a function of the 
center of mass collision energy (ECM) during CID of mass-selected a) [
195
Pt(NH3)(G)
35
Cl]
+
 
(m/z 398), b) [
195
Pt(NH3)(A)
35
Cl]
+
 (m/z 382)  and c) [
195
Pt(A)(G)(-H)]
+ 
(m/z 480) ions. See 
text for details 
 
Figure 2. Geometries and relative free energies (kJ mol
-1
, in parentheses) for 
represnentative cis-[Pt(NH3)2(G)Cl]
+ 
 structures calculated at the B3LYP/6-311G** level. 
Distances are given in Angström. Relative free energies given in italic were obtained by 
using the Polarized Continuum Model (PCM) approach 
 
Figure 3. a) Experimental IRMPD spectrum of cis-[Pt(NH3)2(G)Cl]
+ 
obtained with full 
(green) and attenuated (by a factor of two, red) laser power together with computed IR 
spectra of b) PtGN7-1 c) PTGO-1, d) PtGO-2 and e) PtGN3, all calculated at the B3LYP/ 
6-311G** level in the spectral range of 950-1900 cm
-1
. 
 
Figure 4. a) Experimental IRMPD spectrum of cis-[Pt(NH3)2(G)Cl]
+ 
obtained with an 
irradiation time of 1 second (green) and 2 second (blue) respectively, together with 
computed IR spectra of b) PtGN7-1, c) PTGO-1, d) PtGO-2 and e) PtGN3, all calculated 
at the B3LYP/ 6-311G** level in the spectral range of 2900-3700 cm
-1
. 
 
Figure 5. Geometries and relative free energies (kJ mol
-1
, in parentheses) for representative 
cis-[Pt(NH3)2(A)Cl]
+ 
 structures calculated at the B3LYP/6-311G** level. Distances are 
given in Angströms. Relative free energies given in italic were obtained by using the 
Polarized Continuum Model (PCM) approach 
 
Figure 6. a) Experimental IRMPD spectrum of cis-[Pt(NH3)2(A)Cl]
+ 
together with 
computed IR spectra of b) PtAN3, c) PtAN1, d) PtAN7, e) PtAN9N7t and f) PtAN3N7t, 
all calculated at the B3LYP/ 6-311G** level, in the spectral range of 1000-1900 cm
-1. 
Computed intensities are displayed between 0 and 1000 km/mol.
  
 
Figure 7. a) Experimental IRMPD spectrum of cis-[Pt(NH3)2(A)Cl]
+ 
together with 
computed IR spectra of b) PtAN3, c) PtAN1, d) PtAN7, e) PtAN9N7t and f) PtAN3N7t,, 
all calculated at the at the B3LYP/ 6-311G** level, in the spectral range of 3000-3700 cm
-1.
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Figure 1. Relative abundances of the precursor ion and fragment ions as a function of the 
center of mass collision energy (ECM) during CID of mass-selected a) [
195
Pt(NH3)(G)
35
Cl]
+
 
(m/z 398), b) [
195
Pt(NH3)(A)
35
Cl]
+
 (m/z 382)  and c) [
195
Pt(A)(G)(-H)]
+ 
(m/z 480) ions. See 
text for details 
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Figure 2. Geometries and relative free energies (kJ mol
-1
, in parentheses) for representative 
cis-[Pt(NH3)2(G)Cl]
+ 
 structures calculated at the B3LYP/6-311G** level. Distances are 
given in Angströms. Relative free energies given in italic were obtained by using the 
Polarized Continuum Model (PCM) approach  
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Figure 3. a) Experimental IRMPD spectrum of cis-[Pt(NH3)2(G)Cl]
+ 
obtained with full 
(green) and attenuated (by a factor of two, red) laser power together with computed IR spectra 
of b) PtGN7-1 c) PTGO-1, d) PtGO-2 and e) PtGN3, all calculated at the B3LYP/ 6-311G** 
level in the spectral range of 950-1900 cm
-1
. 
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Figure 4. a) Experimental IRMPD spectrum of cis-[Pt(NH3)2(G)Cl]
+ 
obtained with an 
irradiation time of 1 second (green) and 2 second (blue) respectively, together with 
computed IR spectra of b) PtGN7-1, c) PTGO-1, d) PtGO-2 and e) PtGN3, all calculated 
at the B3LYP/ 6-311G** level in the spectral range of 2900-3700 cm
-1
. 
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Figure 5. Geometries and relative free energies (kJ mol
-1
, in parentheses) for representative 
cis-[Pt(NH3)2(A)Cl]
+ 
 structures calculated at the B3LYP/6-311G** level. Distances are 
given in Angströms. Relative free energies given in italic were obtained by using the 
Polarized Continuum Model (PCM) approach 
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Figure 6. a) Experimental IRMPD spectrum of cis-[Pt(NH3)2(A)Cl]
+ 
together with 
computed IR spectra of b) PtAN3, c) PtAN1, d) PtAN7, e) PtAN9N7t and f) PtAN3N7t, all 
calculated at the at the B3LYP/ 6-311G** level, in the spectral range of 1000-1900 cm
-1 
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Figure 7. a) Experimental IRMPD spectrum of cis-[Pt(NH3)2(A)Cl]
+ 
together with 
computed IR spectra of b) PtAN3, c) PtAN1, d) PtAN7, e) PtAN9N7t and f) PtAN3N7t, all 
calculated at the at the B3LYP/ 6-311G** level, in the spectral range of 3000-3700 cm
-1.
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